1. Orphan products: origins, progress, and prospects;Haffner;Ann Rev Pharmacol Toxicol,1991
2. Unites States Public Law;Orphan Drug Act (ODA),1982
3. Incentives for ‘orphan drugs’ makers voted;United States Congress,1983
4. A new look at the returns and risks to pharmaceutical R&D;Grabowski;Manag Sci,1990
5. The pharmaceutical development process: estimates of development costs and times and effects in proposed regulatory changes;Hansen,1980